RecruitingPhase 2

Reinforced Pancreaticojejunostomy With or Without glubran2

Egypt100 participantsStarted 2025-01-15

Plain-language summary

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All the patients undergoing pancreaticoduodenectomy for cancer * Patients able to give their informed consent Exclusion Criteria: * Unfit patients for surgery due to severe medical illness. * Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy. * Presence of distant metastasis . * Patients refused to participate in the study.

What they're measuring

the rate of Postoperative pancreatic fistula within 2 weeks after operation

Timeframe: within 2 weeks after operation

Trial details

NCT IDNCT06756074

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-15

Contact for this trial

Saleh K Saleh, MD

01201765401 salehkhairy@mu.edu.eg

View on ClinicalTrials.gov More Pancreatic Fistula trials